Literature DB >> 9614501

Early changes in excitation-contraction coupling: transition from compensated hypertrophy to failure in Dahl salt-sensitive rat myocytes.

K Nagata1, R Liao, F R Eberli, N Satoh, B Chevalier, C S Apstein, T M Suter.   

Abstract

OBJECTIVE: The aims were to (1) define the early changes in excitation-contraction coupling during the transition from cardiac hypertrophy to heart failure, and (2) to clarify the causal relationship between mechanical dysfunction and abnormal Ca2+ handling in the Dahl salt-sensitive rat model.
METHODS: Myocardial contractile function was assessed in whole heart perfusion studies. In separate experiments, isolated left ventricular myocytes from Dahl salt-sensitive (DS) and Dahl salt-resistant (DR) rats were paced at a physiological rate of 5Hz and cell shortening (CS) and [Ca2+]i measured simulataneously by video-edge detection and fura-2 fluorescence.
RESULTS: DS hearts developed hypertrophy after 4 weeks of a high-salt diet (4WHSD), as indicated by a 26% increase (p < 0.01) in the heart to body weight ratio and a 21% increase (p < 0.01) in cell width. Heart failure developed after 12 weeks of a high-salt diet (12WHSD), as indicated by an 11% increase (p < 0.01) in the lung wet to dry weight ratio. Furthermore, in DS-12WHSD hearts, the diastolic pressure-volume relationship had shifted rightward. DR rats did not develop hypertension and seved as age-matched controls. A 31% (p < 0.05) increase in the %CS in DS-4WHSD myocytes compared to DR-4WHSD myocytes with a trend of a parallel increase in Ca2+ transient amplitude was found. There was no difference in the Ca2+ transient parameters between DR and DS at 12WHSD, but an 18% (p < 0.01) decrease occurred in peak [Ca2+]i in DS myocytes between 4WHSD and 12WHSD. In DS-12WHSD, the time to peak shortening and the time from peak shortening to 50% and 90% relaxation was significantly prolonged by 27%, 44%, and 38%, respectively, as compared to the age-matched DR myocytes.
CONCLUSION: Our results indicated that: (I) normal Ca2+ homeostasis is preserved at the stage of compensated hypertrophy; (2) the early signs of isolated myocyte dysfunction were a prolongation of the shortening and relaxation time course without an abnormal time course of the Ca2+ transient. Thus, in the hypertensive Dahl salt rat model, abnormal Ca2+ handling appears neither to precede nor initiate the transition to failure.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614501     DOI: 10.1016/s0008-6363(97)00278-2

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  18 in total

1.  Changes in the chemical and dynamic properties of cardiac troponin T cause discrete cardiomyopathies in transgenic mice.

Authors:  Briar R Ertz-Berger; Huamei He; Candice Dowell; Stephen M Factor; Todd E Haim; Sara Nunez; Steven D Schwartz; Joanne S Ingwall; Jil C Tardiff
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-02       Impact factor: 11.205

2.  β2-adrenergic receptors mediate cardioprotection through crosstalk with mitochondrial cell death pathways.

Authors:  Giovanni Fajardo; Mingming Zhao; Gerald Berry; Lee-Jun Wong; Daria Mochly-Rosen; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2011-07-02       Impact factor: 5.000

3.  Critical role for stromal interaction molecule 1 in cardiac hypertrophy.

Authors:  Jean-Sébastien Hulot; Jérémy Fauconnier; Deepak Ramanujam; Antoine Chaanine; Fleur Aubart; Yassine Sassi; Sabine Merkle; Olivier Cazorla; Aude Ouillé; Morgan Dupuis; Lahouaria Hadri; Dongtak Jeong; Silke Mühlstedt; Joachim Schmitt; Attila Braun; Ludovic Bénard; Youakim Saliba; Bernhard Laggerbauer; Bernhard Nieswandt; Alain Lacampagne; Roger J Hajjar; Anne-Marie Lompré; Stefan Engelhardt
Journal:  Circulation       Date:  2011-08-01       Impact factor: 29.690

4.  Myocardial energetics is not compromised during compensated hypertrophy in the Dahl salt-sensitive rat model of hypertension.

Authors:  Kenneth Tran; June-Chiew Han; Andrew J Taberner; Carolyn J Barrett; Edmund J Crampin; Denis S Loiselle
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-07-08       Impact factor: 4.733

5.  Pharmacological inhibition of βIIPKC is cardioprotective in late-stage hypertrophy.

Authors:  Julio C B Ferreira; Tomoyoshi Koyanagi; Suresh S Palaniyandi; Giovanni Fajardo; Eric N Churchill; Grant Budas; Marie-Helene Disatnik; Daniel Bernstein; Patricia C Brum; Daria Mochly-Rosen
Journal:  J Mol Cell Cardiol       Date:  2011-09-02       Impact factor: 5.000

6.  Prevention of ventricular arrhythmia and calcium dysregulation in a catecholaminergic polymorphic ventricular tachycardia mouse model carrying calsequestrin-2 mutation.

Authors:  Ronny Alcalai; Hiroko Wakimoto; Michael Arad; David Planer; Tetsuo Konno; Libin Wang; Jon G Seidman; Christine E Seidman; Charles I Berul
Journal:  J Cardiovasc Electrophysiol       Date:  2010-08-30

7.  Endogenous regulation of cardiovascular function by apelin-APJ.

Authors:  David N Charo; Michael Ho; Giovanni Fajardo; Masataka Kawana; Ramendra K Kundu; Ahmad Y Sheikh; Thomas P Finsterbach; Nicholas J Leeper; Kavita V Ernst; Mary M Chen; Yen Dong Ho; Hyung J Chun; Daniel Bernstein; Euan A Ashley; Thomas Quertermous
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-09-18       Impact factor: 4.733

8.  Deletion of the β2-adrenergic receptor prevents the development of cardiomyopathy in mice.

Authors:  Giovanni Fajardo; Mingming Zhao; Takashi Urashima; Sara Farahani; Dong-Qing Hu; Sushma Reddy; Daniel Bernstein
Journal:  J Mol Cell Cardiol       Date:  2013-08-03       Impact factor: 5.000

9.  Calsequestrin 2 (CASQ2) mutations increase expression of calreticulin and ryanodine receptors, causing catecholaminergic polymorphic ventricular tachycardia.

Authors:  Lei Song; Ronny Alcalai; Michael Arad; Cordula M Wolf; Okan Toka; David A Conner; Charles I Berul; Michael Eldar; Christine E Seidman; J G Seidman
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808

Review 10.  The cell biology of disease: cellular mechanisms of cardiomyopathy.

Authors:  Pamela A Harvey; Leslie A Leinwand
Journal:  J Cell Biol       Date:  2011-08-08       Impact factor: 10.539

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.